Compare SWBI & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SWBI | RAPP |
|---|---|---|
| Founded | 1852 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Ordnance And Accessories | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 453.6M | 1.2B |
| IPO Year | N/A | 2024 |
| Metric | SWBI | RAPP |
|---|---|---|
| Price | $10.79 | $30.34 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $11.00 | ★ $47.80 |
| AVG Volume (30 Days) | ★ 746.2K | 361.1K |
| Earning Date | 12-04-2025 | 11-06-2025 |
| Dividend Yield | ★ 4.80% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.21 | N/A |
| Revenue | ★ $466,396,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.56 | N/A |
| P/E Ratio | $51.84 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.73 | $6.43 |
| 52 Week High | $11.50 | $42.27 |
| Indicator | SWBI | RAPP |
|---|---|---|
| Relative Strength Index (RSI) | 69.32 | 62.22 |
| Support Level | $10.58 | $27.81 |
| Resistance Level | $11.23 | $31.00 |
| Average True Range (ATR) | 0.38 | 1.84 |
| MACD | 0.28 | 0.11 |
| Stochastic Oscillator | 77.64 | 83.09 |
Smith & Wesson Brands Inc is a U.S.-based leader in firearm manufacturing. It operates under one reportable segment: Firearms, which includes firearms distribution and manufacturing services. The company manufactures handguns, long guns, sporting rifles, shooting gear, and suppressor products. The firm's brand portfolio consists of Smith and Wesson, M&P, Thompson/Center Arms, Performance Center, and Gemtech; which are used for defense, law enforcement, hunting, and sporting purposes. The company operates internationally, with the majority of income generated by the U.S. market from its handgun products.
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.